PL353154A1 - Trwała kompozycja farmaceutyczna do stosowania doustnego - Google Patents

Trwała kompozycja farmaceutyczna do stosowania doustnego

Info

Publication number
PL353154A1
PL353154A1 PL00353154A PL35315400A PL353154A1 PL 353154 A1 PL353154 A1 PL 353154A1 PL 00353154 A PL00353154 A PL 00353154A PL 35315400 A PL35315400 A PL 35315400A PL 353154 A1 PL353154 A1 PL 353154A1
Authority
PL
Poland
Prior art keywords
drug
present
oral use
exposure
during storage
Prior art date
Application number
PL00353154A
Other languages
English (en)
Other versions
PL200645B1 (pl
Inventor
Kazuhiro Sako
Toyohiro Sawada
Keiichi Yoshihara
Tatsunobu Yoshioka
Shunsuke Watanabe
Original Assignee
Yamanouchi Pharmaceutical Co, Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22520720&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL353154(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Yamanouchi Pharmaceutical Co, Ltd. filed Critical Yamanouchi Pharmaceutical Co, Ltd.
Publication of PL353154A1 publication Critical patent/PL353154A1/pl
Publication of PL200645B1 publication Critical patent/PL200645B1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL353154A 1999-08-04 2000-08-01 Trwała kompozycja farmaceutyczna do stosowania doustnego, trwała tabletka farmaceutyczna do stosowania doustnego, sposób wytwarzania trwałej kompozycji farmaceutycznej oraz zastosowanie żółtego tlenku żelazowego lub czerwonego tlenku żelazowego do stabilizowania preparatu PL200645B1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US14722299P 1999-08-04 1999-08-04

Publications (2)

Publication Number Publication Date
PL353154A1 true PL353154A1 (pl) 2003-10-20
PL200645B1 PL200645B1 (pl) 2009-01-30

Family

ID=22520720

Family Applications (1)

Application Number Title Priority Date Filing Date
PL353154A PL200645B1 (pl) 1999-08-04 2000-08-01 Trwała kompozycja farmaceutyczna do stosowania doustnego, trwała tabletka farmaceutyczna do stosowania doustnego, sposób wytwarzania trwałej kompozycji farmaceutycznej oraz zastosowanie żółtego tlenku żelazowego lub czerwonego tlenku żelazowego do stabilizowania preparatu

Country Status (17)

Country Link
EP (1) EP1205190B1 (pl)
JP (1) JP3462490B2 (pl)
KR (1) KR100507400B1 (pl)
CN (1) CN1193792C (pl)
AT (1) ATE324909T1 (pl)
AU (1) AU769807B2 (pl)
CA (1) CA2387705C (pl)
DE (1) DE60027728T2 (pl)
DK (1) DK1205190T3 (pl)
ES (1) ES2262528T3 (pl)
HU (1) HU229295B1 (pl)
MX (1) MXPA02001267A (pl)
NO (1) NO331834B1 (pl)
PL (1) PL200645B1 (pl)
PT (1) PT1205190E (pl)
RU (1) RU2220715C2 (pl)
WO (1) WO2001010466A1 (pl)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003090743A1 (en) * 2002-04-24 2003-11-06 Cypress Bioscience, Inc. Prevention and treatment of functional somatic disorders, including stress-related disorders
US7776314B2 (en) 2002-06-17 2010-08-17 Grunenthal Gmbh Abuse-proofed dosage system
ZA200409537B (en) * 2003-01-31 2006-10-25 Yamanouchi Pharma Co Ltd Stable solid medicinal composition for oral administration
US7442387B2 (en) * 2003-03-06 2008-10-28 Astellas Pharma Inc. Pharmaceutical composition for controlled release of active substances and manufacturing method thereof
DE10361596A1 (de) 2003-12-24 2005-09-29 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
DE102005005446A1 (de) 2005-02-04 2006-08-10 Grünenthal GmbH Bruchfeste Darreichungsformen mit retardierter Freisetzung
DE10336400A1 (de) 2003-08-06 2005-03-24 Grünenthal GmbH Gegen Missbrauch gesicherte Darreichungsform
JP2005162736A (ja) * 2003-11-10 2005-06-23 Astellas Pharma Inc 徐放性医薬組成物
JP2005162737A (ja) * 2003-11-10 2005-06-23 Astellas Pharma Inc 徐放性医薬組成物
US7358270B2 (en) 2004-01-30 2008-04-15 Astellas Pharma Inc. Treating agent for irritable bowel syndrome
RU2253453C1 (ru) * 2004-03-15 2005-06-10 Общество с ограниченной ответственностью "ЮНАЛ" Противовоспалительная и антиаллергическая композиция
DE102004032049A1 (de) 2004-07-01 2006-01-19 Grünenthal GmbH Gegen Missbrauch gesicherte, orale Darreichungsform
RU2279467C1 (ru) * 2005-01-25 2006-07-10 Общество с ограниченной ответственностью "Нурлатский ликеро-водочный завод" Водка "ледок"
DE102005005449A1 (de) 2005-02-04 2006-08-10 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
JP4632204B2 (ja) * 2005-09-21 2011-02-16 アステラス製薬株式会社 下痢型過敏性腸症候群治療剤
TWI478712B (zh) 2008-09-30 2015-04-01 Astellas Pharma Inc 釋控性醫藥組成物
WO2010084397A2 (en) * 2009-01-20 2010-07-29 Micro Labs Limited Modified release solid pharmaceutical compositions of trimetazidine and process thereof
ES2428938T3 (es) 2009-07-22 2013-11-12 Grünenthal GmbH Forma de dosificación resistente a la manipulación y estabilizada frente a la oxidación
BR112012001547A2 (pt) 2009-07-22 2016-03-08 Gruenenthal Gmbh forma de dosagem farmacêutica extrusada por fusão a quente
RU2442586C1 (ru) * 2009-11-11 2012-02-20 Учреждение Белорусского государственного университета "Научно-исследовательский институт физико-химических проблем" (НИИ ФХП БГУ) Гидрогелевый противоопухолевый препарат
JP5849947B2 (ja) 2010-03-29 2016-02-03 アステラス製薬株式会社 放出制御医薬組成物
CA2808219C (en) 2010-09-02 2019-05-14 Gruenenthal Gmbh Tamper resistant dosage form comprising inorganic salt
KR102027912B1 (ko) 2011-02-15 2019-10-02 지엘팜텍주식회사 경구투여용 탐술로신 또는 이의 약제학적으로 허용되는 염을 포함하는 서방성 삼중정제
CA2839123A1 (en) 2011-07-29 2013-02-07 Grunenthal Gmbh Tamper-resistant tablet providing immediate drug release
PL2736497T3 (pl) 2011-07-29 2018-01-31 Gruenenthal Gmbh Tabletka odporna na ingerencję, zapewniająca natychmiastowe uwalnianie leku
PL2838512T3 (pl) 2012-04-18 2018-12-31 Grünenthal GmbH Farmaceutyczna postać dawkowania odporna na niewłaściwe użycie i odporna na uderzeniowe uwalnianie dawki
US10064945B2 (en) 2012-05-11 2018-09-04 Gruenenthal Gmbh Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc
MX371432B (es) 2013-05-29 2020-01-30 Gruenenthal Gmbh Forma de dosificacion resistente al uso indebido que contiene una o mas particulas.
US10624862B2 (en) 2013-07-12 2020-04-21 Grünenthal GmbH Tamper-resistant dosage form containing ethylene-vinyl acetate polymer
WO2015078891A1 (en) 2013-11-26 2015-06-04 Farmaceutici Formenti S.P.A. Preparation of a powdery pharmaceutical composition by means of cryo-milling
US20150320690A1 (en) 2014-05-12 2015-11-12 Grünenthal GmbH Tamper resistant immediate release capsule formulation comprising tapentadol
EP3148512A1 (en) 2014-05-26 2017-04-05 Grünenthal GmbH Multiparticles safeguarded against ethanolic dose-dumping
CA2980096C (en) 2015-03-19 2019-12-17 Daiichi Sankyo Company, Limited Solid preparations of [(1r,5s,6s)-6-(aminomethyl)-3-ethylbicyclo[3.2.0]hept-3-en-6-yl]acetic acid monobenzenesulfonate stabilized by containing a specific antioxidant, and methodsfor preparing the same
CN107427483B (zh) * 2015-03-19 2021-06-29 第一三共株式会社 含有着色剂的固体制剂
BR112017021475A2 (pt) 2015-04-24 2018-07-10 Gruenenthal Gmbh forma de dosagem resistente à adulteração (tamper) com liberação imediata e resistência contra extração de solvente
TWI722988B (zh) 2015-06-05 2021-04-01 瑩碩生技醫藥股份有限公司 緩釋性醫藥組合物及其製備方法
AU2016319203A1 (en) 2015-09-10 2018-02-22 Grünenthal GmbH Protecting oral overdose with abuse deterrent immediate release formulations
EP3360866B1 (en) 2017-02-14 2019-01-02 Alfred E. Tiefenbacher (GmbH & Co. KG) Mirabegron prodrugs
US12083226B2 (en) 2018-07-30 2024-09-10 Daiichi Sankyo Company, Limited Stabilizer-containing solid drug formulation
EP3722285B1 (en) 2020-04-08 2022-03-30 Alfred E. Tiefenbacher (GmbH & Co. KG) Process for preparing mirabegron enacarbil
US12097189B1 (en) 2024-02-09 2024-09-24 Astellas Pharma Inc. Pharmaceutical composition for modified release

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU198844B (en) * 1984-06-14 1989-12-28 Sandoz Ag Process for producing new galenic pharmaceutical composition ensuring retarded release of active ingredient
ZA87279B (en) * 1986-01-17 1987-09-30 Chugai Pharmaceutical Co Ltd Method for production of stable nicorandil preparation
US4859470A (en) * 1988-06-02 1989-08-22 Alza Corporation Dosage form for delivering diltiazem
HU206824B (en) * 1990-08-24 1993-01-28 Biogal Gyogyszergyar Process for the production of a table crystallizing in the monoclinic system, which contains light-, heat-, and moisture- sensitive active agents
JP2820829B2 (ja) * 1991-03-07 1998-11-05 武田薬品工業株式会社 有核散剤およびその製造方法
JPH04346929A (ja) * 1991-05-22 1992-12-02 Takada Seiyaku Kk 光に安定なメシル酸ブロモクリプチン製剤
ATE214596T1 (de) * 1995-04-14 2002-04-15 Pharma Pass Feste zusammensetzungen mit einem nicht-amorphem wirkstoff und polyäthylenoxyd
RU2092161C1 (ru) * 1995-06-23 1997-10-10 Санкт-Петербургская Государственная Химико-Фармацевтическая Академия Средство с регулируемым высвобождением пентоксифиллина
EP0991409B1 (en) * 1997-08-01 2002-01-30 ELAN CORPORATION, Plc Controlled release pharmaceutical compositions containing tiagabine
EP0901787B1 (en) * 1997-09-10 2003-05-28 Takeda Chemical Industries, Ltd. Stabilized pharmaceutical composition

Also Published As

Publication number Publication date
PT1205190E (pt) 2006-09-29
CN1373673A (zh) 2002-10-09
DE60027728T2 (de) 2007-04-26
NO20020516L (no) 2002-02-01
KR20020046277A (ko) 2002-06-20
JP3462490B2 (ja) 2003-11-05
MXPA02001267A (es) 2002-08-12
CN1193792C (zh) 2005-03-23
WO2001010466A1 (fr) 2001-02-15
KR100507400B1 (ko) 2005-08-10
EP1205190A4 (en) 2004-01-21
NO331834B1 (no) 2012-04-16
AU6182100A (en) 2001-03-05
PL200645B1 (pl) 2009-01-30
RU2220715C2 (ru) 2004-01-10
ATE324909T1 (de) 2006-06-15
DK1205190T3 (da) 2006-08-14
EP1205190B1 (en) 2006-05-03
DE60027728D1 (de) 2006-06-08
HU229295B1 (en) 2013-10-28
AU769807B2 (en) 2004-02-05
CA2387705A1 (en) 2001-02-15
CA2387705C (en) 2009-06-30
HUP0202495A3 (en) 2004-05-28
EP1205190A1 (en) 2002-05-15
ES2262528T3 (es) 2006-12-01
HUP0202495A2 (hu) 2002-11-28
NO20020516D0 (no) 2002-02-01

Similar Documents

Publication Publication Date Title
EP1205190A4 (en) STABLE MEDICAL COMPOSITIONS FOR ORAL USE
RU2002102701A (ru) Стабильная пероральная образующая гидрогель, фармацевтическая композиция, способ ее получения, способ предотвращения изменений высвобождения лекарственного средства, способ увеличения физической стабильности пероральной композиции
GEP20022851B (en) Flash-Melt Oral Dosage Formulation
HUP0203451A2 (hu) Új, tuberkolózis elleni gyógyszerkészítmények és eljárás előállításukra
IE970588A1 (en) Controlled release pharmaceutical compositions containing tiagabine
DE60036807D1 (de) Verfahren zur herstellung eines pharmazeutischen kaugummis
WO2004108162A3 (en) Controlled release pharmaceutical composition
ATE130758T1 (de) Arzneimittel zur intranasalen verabreichung, die ketorolac r enthalten.
DE69528838T2 (de) Verbesserte,ibuprofen und codein enthaltende,pharmazeutische zusammensetzungen
DE69201956D1 (de) Pyrrolidin- und thiazolidinderivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel.
ATE108650T1 (de) Methode und zusammensetzung zur oralen verabreichung von bioaktiven mitteln zur peyer's flecken.
WO2002098345A8 (fr) Utilisation d'un antioxydant pour le traitement et/ou la prevention des affections oculaires de surface
MY130098A (en) Local drug delivery film for periodontal treatment
MY127350A (en) Flash-melt oral dose formulations
AP2003002763A0 (en) Controlled release formulations for oral administration
DE60042972D1 (de) Trimetazidine enthaltendes Arzneimittel mit verzögerter Wirkstoffabgabe und Verfahren zur Herstellung
NL8600302A (nl) Farmaceutische preparaten met analgetische werkzaamheid, alsmede de bereiding en toepassing ervan.
DE69723024D1 (de) Pharmazeutische Zusammensetzungen mit kontrollierter Freisetzung zur oralen Verabreichung enthaltend Nifedipin als Wirkstoff
ATE367153T1 (de) Multipartikuläre arzneizusammensetzungen mit gesteuerter wirkstoffabgabe enthaltend selektive inhibitoren der serotoninwiederaufnahme
ATE285252T1 (de) Mittel zur verhinderung der truebung der vorderen linsenkapsel
WO1999047172A3 (en) Oral pharmaceutical compositions to be taken without liquids, which contain inclusion complexes
DE69209916D1 (de) Oral anzuwendende Arzneimittel Dapiprazol enthaltend
YU81101A (sh) Polimorfni oblici kristalnog citrata azabiciklo (2,2,2) oktan-3-amina i njihovih farmaceutskih kompozicija
ATE212840T1 (de) Oral anzuwendende feste arzneizubereitungen mit modulierter wirkstoffabgabe enthaltend nicorandil und verfahren zu deren herstellung
ATE85218T1 (de) Oral anzuwendende arzneiform zur einmal taeglichen behandlung der hypertonie mit diltiazemhydrochlorid.